Patents by Inventor Anthony Boral

Anthony Boral has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION OF CERTINIB WITH AN EGFR INHIBITOR
    Publication number: 20200085814
    Abstract: The present disclosure relates to a pharmaceutical composition comprising two Tyrosine Kinase Inhibitors (TKIs), namely Ceritinib and an EGFR Inhibitor. The present combination can be administered independently or separately, in a quantity which is jointly therapeutically effective for the treatment of a TKI mediated disease, such as cancer. The disclosure also provides the use of such a combination for the manufacture of a medicament; the use of such a combination as a medicine; a kit of part comprising such a combination; and a method of treatment of such a combination.
    Type: Application
    Filed: September 24, 2019
    Publication date: March 19, 2020
    Inventors: Serafino Pantano, Fang Li, Nanxin Li, Anthony Boral
  • Combination of Ceritinib with an EGFR Inhibitor
    Publication number: 20170252335
    Abstract: The present disclosure relates to a pharmaceutical composition comprising two Tyrosine Kinase Inhibitors (TKIs), namely Ceritinib and an EGFR Inhibitor. The present combination can be administered independently or separately, in a quantity which is jointly therapeutically effective for the treatment of a TKI mediated disease, such as cancer. The disclosure also provides the use of such a combination for the manufacture of a medicament; the use of such a combination as a medicine; a kit of part comprising such a combination; and a method of treatment of such a combination.
    Type: Application
    Filed: October 15, 2015
    Publication date: September 7, 2017
    Applicant: Novartis AG
    Inventors: Serafino Pantano, Fang Li, Nanxin Li, Anthony Boral